Academic Journal
Q1American Journal of Respiratory and Critical Care Medicine
About American Journal of Respiratory and Critical Care Medicine
American Journal of Respiratory and Critical Care Medicine is a scholarly journal published by American Thoracic Society. SCImago 2025 places it in Q1 with an SJR of 5.423 and an H-index of 450.
Its listed coverage is 1991, 1994-2026 and its research categories include Critical Care and Intensive Care Medicine (Q1); Pulmonary and Respiratory Medicine (Q1). The 2025 dataset reports 451 documents and 11771 citations across the latest three-year reporting window.
The American Journal of Respiratory and Critical Care Medicine (AJRCCM) is a leading peer-reviewed medical journal published by the American Thoracic Society (ATS). It is globally recognized as a top-tier resource in the fields of pulmonary medicine, critical care, and sleep medicine. Established with a mission to improve respiratory health, the journal publishes cutting-edge research that shapes clinical practice and advances medical knowledge.
High-Impact Respiratory and Critical Care Research
AJRCCM publishes original research articles, clinical trials, systematic reviews, and meta-analyses that focus on respiratory and critical care topics. The journal’s scope includes, but is not limited to, chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, lung infections, acute respiratory distress syndrome (ARDS), mechanical ventilation, and sepsis management. It also covers innovative topics such as genomic medicine, biomarkers, and novel therapeutic strategies.
With an emphasis on both clinical and translational research, AJRCCM bridges the gap between laboratory discoveries and patient care. Its articles provide the latest insights that help clinicians diagnose, treat, and manage complex respiratory and critical illnesses effectively.
Trusted by Healthcare Professionals Worldwide
As one of the most cited and respected journals in respiratory medicine, the American Journal of Respiratory and Critical Care Medicine serves as a vital resource for pulmonologists, intensivists, respiratory therapists, and other healthcare professionals. Its content directly influences clinical guidelines, hospital protocols, and global healthcare standards. Many of the studies published in AJRCCM have contributed to evidence-based practices and policy-making in healthcare systems worldwide.
The journal is also widely used in academic settings for teaching and research, making it an essential tool for medical students, residents, and fellows pursuing careers in pulmonary and critical care specialties.
Peer-Reviewed Excellence and Editorial Integrity
AJRCCM maintains rigorous editorial standards and a comprehensive peer-review process. Its editorial board includes renowned experts and researchers in respiratory and critical care medicine. This ensures that all published content is scientifically sound, ethically responsible, and clinically relevant.
The journal's high impact factor reflects its influence and reputation in the medical community. It is indexed in major databases including PubMed, Scopus, Web of Science, and MEDLINE, ensuring global visibility and accessibility.
Educational Resources and Continuing Learning
In addition to research articles, AJRCCM offers editorials, clinical perspectives, commentaries, and case reports that enhance understanding and support professional development. These resources help practitioners stay current with evolving trends and best practices in respiratory care.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The American Journal of Respiratory and Critical Care Medicine (AJRCCM), published by the American Thoracic Society (ATS), is a leading peer-reviewed medical journal dedicated to publishing the most current and significant advancements in respiratory, pulmonary, and critical care medicine. Its comprehensive scope makes it a trusted resource for clinicians, researchers, educators, and policymakers worldwide. The journal aims to enhance the understanding, diagnosis, and treatment of respiratory diseases and critical illnesses by presenting groundbreaking research and clinical insights.
Comprehensive Focus on Pulmonary Medicine
AJRCCM covers an extensive array of topics in pulmonary medicine, ranging from common respiratory conditions to rare and complex lung diseases. These include:
-
Asthma and allergic airway diseases
-
Chronic obstructive pulmonary disease (COPD)
-
Interstitial lung diseases, including idiopathic pulmonary fibrosis (IPF)
-
Pulmonary hypertension
-
Lung infections such as pneumonia and tuberculosis
-
Lung cancer and thoracic oncology
-
Environmental and occupational lung diseases
Research published in the journal often explores mechanisms of disease, diagnostic biomarkers, imaging techniques, and emerging therapies, helping to drive innovation in pulmonary care and improve patient outcomes.
In-Depth Coverage of Critical Care Medicine
The critical care medicine scope of AJRCCM includes all aspects of intensive care management and life-threatening conditions. Topics regularly addressed include:
-
Acute respiratory distress syndrome (ARDS)
-
Sepsis and septic shock
-
Mechanical ventilation and weaning strategies
-
Extracorporeal membrane oxygenation (ECMO)
-
Hemodynamic monitoring and resuscitation
-
ICU protocols, sedation, and delirium management
-
Ethics and end-of-life care in the ICU
AJRCCM serves as a key source of evidence-based practice for intensivists, critical care nurses, and ICU teams, ensuring the best standards of care for critically ill patients.
Bridging Basic Science and Clinical Practice
A distinctive feature of AJRCCM is its integration of translational research that bridges laboratory science with clinical application. The journal regularly features studies on:
-
Molecular biology and genetics of lung diseases
-
Immunology and inflammation
-
Cellular responses and tissue remodeling
-
Gene-environment interactions in respiratory health
This commitment to basic and translational science helps foster new therapeutic approaches and personalized medicine strategies in respiratory and critical care.
Sleep Medicine and Respiratory Health
AJRCCM also includes significant contributions in the field of sleep medicine, particularly research related to:
-
Obstructive sleep apnea
-
Sleep-disordered breathing
-
Impact of sleep on respiratory and cardiovascular health
As sleep disorders become increasingly recognized for their role in chronic disease, AJRCCM plays an important role in advancing this evolving area of study.
Global Health, Policy, and Education
Beyond clinical and laboratory research, AJRCCM addresses global respiratory health challenges, healthcare policy, and educational innovations. Articles often focus on disparities in care, global burden of disease, and strategies to improve access to respiratory care in low- and middle-income countries.
Recent Research Articles
Latest publications matched automatically by ISSN.
Phenotypes of all isogenic mice with pneumococcal pneumonia are equal, or are they?
Dario von Wedel, Martin Witzenrath
2026-09-08 · DOI: 10.1093/ajrccm/aamag449Bile Acid Dysregulation in PAH: Strengthening the Liver–Lung Axis in Pulmonary Vascular Disease
Vishal N Rao, Kurt W Prins
2026-09-04 · DOI: 10.1093/ajrccm/aamag454Beyond Event Frequency: Respiratory Effort Reveals Mortality Risk in Obstructive Sleep Apnea
Nasim Montazeri, Ankit Parekh
2026-09-04 · DOI: 10.1093/ajrccm/aamag452The nexus of NEXIS – underscoring the need for rehabilitation for the critically ill patient
Michelle E Kho, Rik Gosselink
2026-09-04 · DOI: 10.1093/ajrccm/aamag455What Is Hantavirus?
Shazia Jamil, Charles Dela Cruz, Jane E Gross
2026-09-03 · DOI: 10.1093/ajrccm/aamag395Reply to Liao and Zheng: Piperacillin-Tazobactam in High WBC Patients: Promising Signal, Premature Conclusion
Daniel I Rzewnicki, Rishi Chanderraj, Sivasubramanium V Bhavani
2026-09-02 · DOI: 10.1093/ajrccm/aamag443Piperacillin-Tazobactam in High WBC Patients: Promising Signal, Premature Conclusion
Rongqiang Liao, Xiaoyuan Zheng
2026-09-02 · DOI: 10.1093/ajrccm/aamag442Pulmonary Vascular Remodeling Revealed by Spectral CT After Pulmonary Vein Stents Implantation
Yong Luo, XueFeng Wang, Jing Chen, Yi Zhong et al.
2026-08-31 · DOI: 10.1093/ajrccm/aamag440Circulating Bile Acids and Clinical Outcomes in Pulmonary Arterial Hypertension
Nadine Al-Naamani, Hyo-Jin Park, Michael B Fallon, Huiping Zhou et al.
2026-08-26 · DOI: 10.1093/ajrccm/aamag437Impact of a Large-Scale Mold Intervention in Public Housing on Asthma Emergency Department Visits
Nina M Flores, Joan A Casey, Stephanie Lovinsky-Desir, Ariel Spira-Cohen et al.
2026-08-25 · DOI: 10.1093/ajrccm/aamag441Emerging Investigators Highlight
2026-09-01 · DOI: 10.1093/ajrccm/aamag400Failure of ECCO₂R, or failure of the delivered extracorporeal dose?
Raphaël Giraud, Benjamin Assouline, Carlo Banfi, Karim Bendjelid et al.
2026-08-22 · DOI: 10.1093/ajrccm/aamag438Asymptomatic tuberculosis: new insights and knowledge gaps
Alvin Kuo Jing Teo, Thanh Van Nguyen, Emily L MacLean, Thu Anh Nguyen et al.
2026-08-22 · DOI: 10.1093/ajrccm/aamag444Reply to Giraud et al .: Failure of ECCO₂R, or failure of the delivered extracorporeal dose?
Arthur S Slutsky, Daniel Brodie
2026-08-22 · DOI: 10.1093/ajrccm/aamag439Reply to Li et al.: Beyond right ventricular injury: toward a full-chain right-heart monitoring framework in acute respiratory distress syndrome
Douglas Slobod, Hakeem Yusuff, Vasileios Zochios
2026-09-01 · DOI: 10.1093/ajrccm/aamag323Bronchiolocentric interstitial pneumonia as a new IP entity causes more chaos than advancement
Martina Koziar Vasakova
2026-08-17 · DOI: 10.1093/ajrccm/aamag417Reply to Vasakova: Bronchiolocentric interstitial pneumonia as a new IP entity causes more chaos than advancement
Christopher J Ryerson, Lida P Hariri, Sara Piciucchi, Andrew G Nicholson et al.
2026-08-17 · DOI: 10.1093/ajrccm/aamag419A rare case of primary pulmonary artery large cell neuroendocrine carcinoma
Runcai Guo, Hongyan Liu, Min Liu, Yanan Zhen et al.
2026-09-01 · DOI: 10.1093/ajrccm/aamag319Estimating Inspiratory Effort during Noninvasive Ventilation: No Longer Out of Reach
Evangelia Akoumianaki, Guillaume Carteaux
2026-08-14 · DOI: 10.1093/ajrccm/aamag423Interpreting Post-Tuberculosis Lung Disease after Extrapulmonary Tuberculosis
Mei Liang, Jianqing He, Junyan Qu
2026-08-12 · DOI: 10.1093/ajrccm/aamag424Reviews
Community Reviews
Version History
April 21, 2025 at 1:56 pm
April 21, 2025